Literature DB >> 10839547

CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.

A T Hark1, C J Schoenherr, D J Katz, R S Ingram, J M Levorse, S M Tilghman.   

Abstract

The Insulin-like growth factor 2 (Igf2) and H19 genes are imprinted, resulting in silencing of the maternal and paternal alleles, respectively. This event is dependent upon an imprinted-control region two kilobases upstream of H19 (refs 1, 2). On the paternal chromosome this element is methylated and required for the silencing of H19 (refs 2-4). On the maternal chromosome the region is unmethylated and required for silencing of the Igf2 gene 90 kilobases upstream. We have proposed that the unmethylated imprinted-control region acts as a chromatin boundary that blocks the interaction of Igf2 with enhancers that lie 3' of H19 (refs 5, 6). This enhancer-blocking activity would then be lost when the region was methylated, thereby allowing expression of Igf2 paternally. Here we show, using transgenic mice and tissue culture, that the unmethylated imprinted-control regions from mouse and human H19 exhibit enhancer-blocking activity. Furthermore, we show that CTCF, a zinc finger protein implicated in vertebrate boundary function, binds to several sites in the unmethylated imprinted-control region that are essential for enhancer blocking. Consistent with our model, CTCF binding is abolished by DNA methylation. This is the first example, to our knowledge, of a regulated chromatin boundary in vertebrates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839547     DOI: 10.1038/35013106

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  588 in total

1.  The non-coding RNAs as riboregulators.

Authors:  V A Erdmann; M Z Barciszewska; M Szymanski; A Hochberg; N de Groot; J Barciszewski
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Establishment and maintenance of DNA methylation patterns in mouse Ndn: implications for maintenance of imprinting in target genes of the imprinting center.

Authors:  M L Hanel; R Wevrick
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Cancer epigenetics takes center stage.

Authors:  A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

4.  Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation.

Authors:  A A Wylie; S K Murphy; T C Orton; R L Jirtle
Journal:  Genome Res       Date:  2000-11       Impact factor: 9.043

Review 5.  Above and within the genome: epigenetics past and present.

Authors:  F D Urnov; A P Wolffe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

6.  An intragenic methylated region in the imprinted Igf2 gene augments transcription.

Authors:  A Murrell; S Heeson; L Bowden; M Constância; W Dean; G Kelsey; W Reik
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

7.  Regulation of DNA methylation of Rasgrf1.

Authors:  Bong June Yoon; Herry Herman; Aimee Sikora; Laura T Smith; Christoph Plass; Paul D Soloway
Journal:  Nat Genet       Date:  2001-12-20       Impact factor: 38.330

8.  Multiple nucleosome positioning sites regulate the CTCF-mediated insulator function of the H19 imprinting control region.

Authors:  Meena Kanduri; Chandrasekhar Kanduri; Piero Mariano; Alexander A Vostrov; Wolfgang Quitschke; Victor Lobanenkov; Rolf Ohlsson
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

9.  Methylation-dependent silencing at the H19 imprinting control region by MeCP2.

Authors:  Robert A Drewell; Carolyn J Goddard; Jean O Thomas; M Azim Surani
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

10.  Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities.

Authors:  Félix Recillas-Targa; Michael J Pikaart; Bonnie Burgess-Beusse; Adam C Bell; Michael D Litt; Adam G West; Miklos Gaszner; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.